Comparative Analysis of Pericapsular Nerve Group (PENG) Block Versus Femoral Nerve Block for Postoperative Pain Management in Total Hip Arthroplasty: An Observational Prospective Study

髋关节置换术后疼痛管理中,关节囊周围神经阻滞与股神经阻滞的比较分析:一项前瞻性观察研究

阅读:1

Abstract

INTRODUCTION: Total hip arthroplasty (THA) improves patient mobility and quality of life but is also associated with postoperative pain. Effective pain management is crucial for early postoperative mobility and optimal recovery. Regional analgesia techniques such as femoral nerve block (FNB) are commonly used, but recent studies suggest the pericapsular nerve group (PENG) block may provide superior hip analgesia with less motor impairment. OBJECTIVES: This study compares the effectiveness of PENG block versus FNB concerning postoperative analgesia and motor block sparing in THA patients. MATERIALS AND METHODS: An observational prospective study was conducted at the Unidade Local de Saúde da Região de Leiria, with data collected from January 2023 to April 2024. Patients aged 18 years or older undergoing primary THA and receiving either a PENG block or an FNB were included. RESULTS: A total of 55 patients (17 in the FNB group and 38 in the PENG group) participated in this study. Both blocks effectively reduced postoperative pain scores with no significant differences between groups, demonstrating their efficacy in pain management. Postoperative knee extension motor scores were significantly higher in the PENG group compared to the FNB group (1.52 vs. 1.17, p=0.036), indicating better preservation of motor function. Similarly, leg adduction motor scores were higher in the PENG group than in the FNB group (1.50 vs. 1.29, p=0.02). CONCLUSION: The PENG block demonstrated superior motor function preservation and longer analgesia following THA compared to the FNB. The PENG block may offer a clinical advantage in facilitating earlier mobilization and improving overall recovery outcomes post-surgery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。